Michael J. Massare

Novavax (United States) — United States

Medicine · Health Sciences

22h-index2.8kcitations38works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(17), Respiratory viral infections research(17), Influenza Virus Research Studies(12), COVID-19 Clinical Research Studies(9), Viral gastroenteritis research and epidemiology(6)

Publications38 total

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
Nature Communications·2023· 20 citedOpen Access
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation
Microorganisms·2023· 8 citedOpen Access
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Cell Reports Medicine·2021· 144 citedOpen Access
Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant
2021· 21 cited
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
Research Square (Research Square)·2021· 12 citedOpen Access
Corrigendum to “Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance” [Vaccine 38(43) (2020) 6757–6765]
Vaccine·2021· 1 citedOpen Access
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
2021· 34 citedOpen Access
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Nature Communications·2021· 518 citedOpen Access
Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ Vaccination
SSRN Electronic Journal·2021· 1 citedOpen Access
Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine
Clinical Infectious Diseases·2020· 40 citedOpen Access
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Vaccine·2020· 238 citedOpen Access
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Science·2020· 375 citedOpen Access
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
Vaccines·2020· 22 citedOpen Access
Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunity
2020· 10 citedOpen Access
Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance
Vaccine·2020· 4 citedOpen Access
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
2020· 34 citedOpen Access
Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled Trial
2020· 5 citedOpen Access
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
2020· 40 citedOpen Access
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice
2020· 25 citedOpen Access
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice
2020· 64 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Gale Smith(32), Nita Patel(22), Gregory M. Glenn(22), Bin Zhou(21), Jing-Hui Tian(17), Alyse D. Portnoff(15), Larry Ellingsworth(15), Mimi Guebre‐Xabier(11), Sonia Maciejewski(11), Matthew B. Frieman(11), Louis Fries(11), David C. Flyer(9), Haixia Zhou(8), Greg Glenn(8), James Logue(7), Vivek Shinde(7), Joyce S. Plested(6), Kelsey Jacobson(5), Hanxin Lu(5), Ricardo Carrion(5)